Approval · Notice of Compliance 11809 · 2010
AERIUS: Notice of Compliance 11809
Issued October 14, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11809
- Date
- October 14, 2010
- Company
- Schering-Plough Canada Inc.Pointe-Claire, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Additional indications
- Therapeutic class
- Histamine H1-receptor antagonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AERIUS | Not yet assigned | — |
| AERIUS SYRUP | Not yet assigned | — |
| AERIUS KIDS | Not yet assigned | — |
Medicinal ingredients
- DESLORATADINE 5 MG per TAB
- DESLORATADINE 0.5 MG per ML